| Oct 31 |
bluebird bio (BLUE): Promising Gene Editing Stock with FDA-Approved Therapies
|
| Oct 11 |
Worries Mount Over Cancer Risks in Bluebird Bio's Gene Therapy
|
| Oct 10 |
7 children given bluebird's Skysona developed blood cancer: study
|
| Oct 10 |
Bluebird bio’s Skysona led to seven cases of blood cancer in gene therapy trials
|
| Oct 9 |
Top 10 most shorted stocks on Wall Street
|
| Sep 27 |
Bluebird: Q2 Earnings Snapshot
|
| Sep 27 |
bluebird bio Announces Completion of its Q2 2024 Form 10-Q Filing
|
| Sep 26 |
bluebird bio: Scientific Success And Financial Success, And The Gap Between
|
| Sep 24 |
Gene Therapy-Focused Bluebird Bio Restructures, Cuts Is Workforce By 25%, Seeks To Breakeven Next Year
|
| Sep 24 |
bluebird bio to cut workforce by about 25%
|
